Live Analyst Rating Changes 26571 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Davinthra Thillainathan
GS

Davinthra Thillainathan

Goldman Sachs
Wall Street Analyst
★★☆☆☆
#2309
on 13Foresight · ranked by our own returns
36%
Success Rate
-5.6%
Average Return
4 of 11 calls profitable · +30.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 36% of Davinthra Thillainathan's ratings turned a profit when each position was held for 1 year — averaging -5.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

5 Buy 3 Hold 2 Sell
Davinthra's Stock Coverage 10 ratings · 2026-08-22
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
AU:ACL
Australian Clinical Labs Ltd
 Aug 06, 2026 SELL Hold
-7.5% avg upside
6 analysts
$2.08
28.08% Downside
 -24.4% ·
AU:IDX
Integral Diagnostics Ltd.
 Jun 01, 2026 HOLD Strong Buy
+37.4% avg upside
12 analysts
$2.15
5.69% Downside
 +6.1% ·
AU:ANN
Ansell
 Apr 07, 2026 HOLD Buy
-5.6% avg upside
9 analysts
$31.80
9.88% Downside
 +16.7% ·
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
 Feb 02, 2026 BUY Strong Buy
+26.3% avg upside
11 analysts
$53.20
65.68% Upside
 -11.5% ·
AU:CSL
CSL
 Oct 29, 2025 BUY Strong Buy
+21.6% avg upside
16 analysts
$212.10
23.96% Upside
 -5.1% ·
AU:NAN
Nanosonics Limited
 Sep 25, 2025 BUY Buy
+29.5% avg upside
7 analysts
$6.88
91.20% Upside
 -14.2% ·
AU:RHC
Ramsay Health Care
 Sep 11, 2025 HOLD Hold
-7.3% avg upside
14 analysts
 — +35.3% ·
AU:HLS
Healius Limited
 Aug 12, 2025 SELL Strong Sell
+86.4% avg upside
10 analysts
$0.80
71.94% Upside
 +46.8% ·
AU:COH
Cochlear
Jun 14, 2025 HOLD Hold
+38.8% avg upside
15 analysts
 — -62.8% ·
AU:SHL
Sonic Healthcare Limited
 Apr 03, 2025 BUY Buy
+18.3% avg upside
12 analysts
$32.20
50.66% Upside
 -21.3% ·
🔒 5 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Davinthra Thillainathan — Frequently Asked Questions
How accurate are Davinthra Thillainathan's stock ratings?
Based on the calls 13Foresight could measure, about 36% of Davinthra's ratings were profitable over a one-year hold, with an average return of -5.6% per rating, or +30.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Davinthra ranked on 13Foresight?
Davinthra Thillainathan is currently ranked #2309 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Davinthra cover?
Davinthra most recently has ratings on AU:ACL, AU:IDX, AU:ANN, AU:RMD, AU:CSL, AU:NAN, AU:RHC, AU:HLS, AU:COH, AU:SHL. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.